Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy.
Lazzeri M, Duga S, Azzolini E, Fasulo V, Buffi N, Saita A, Lughezzani G, Paraboschi EM, Hurle R, Nobili A, Cecconi M, Guazzoni G, Casale P, Asselta R; Humanitas COVID-19 Task Force, The Humanitas Gavazzeni COVID-19 Task Force. Lazzeri M, et al. Minerva Urol Nephrol. 2022 Feb;74(1):77-84. doi: 10.23736/S2724-6051.20.04081-3. Epub 2021 Jan 13. Minerva Urol Nephrol. 2022. PMID: 33439572 Free article.
Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).
Labianca R, Pancera G, Aitini E, Barni S, Beretta A, Beretta GD, Cesana B, Comella G, Cozzaglio L, Cristoni M, et al. Labianca R, et al. Among authors: beretta gd, beretta a. Ann Oncol. 1991 Oct;2(9):673-9. doi: 10.1093/oxfordjournals.annonc.a058047. Ann Oncol. 1991. PMID: 1742223 Free article. Clinical Trial.
Editorial: Cross-reactive immunity and COVID-19.
Vojdani A, Yaqinuddin A, Beretta A, Reche PA. Vojdani A, et al. Among authors: beretta a. Front Immunol. 2024 Dec 9;15:1509379. doi: 10.3389/fimmu.2024.1509379. eCollection 2024. Front Immunol. 2024. PMID: 39717772 Free PMC article. No abstract available.
Radiomic features of primary retroperitoneal sarcomas: a prognostic study.
Pasquali S, Iadecola S, Vanzulli A, Infante G, Bologna M, Corino V, Greco G, Vigorito R, Morosi C, Beretta A, Percio S, Vallacchi V, Collini P, Sanfilippo R, Fabbroni C, Stacchiotti S, Fiore M, Huang P, Benelli M, Mainardi L, Miceli R, Gronchi A, Callegaro D. Pasquali S, et al. Among authors: beretta a. Eur J Cancer. 2024 Dec;213:115120. doi: 10.1016/j.ejca.2024.115120. Epub 2024 Nov 9. Eur J Cancer. 2024. PMID: 39541785 Free article.
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.
Stacchiotti S, Martini S, Pasquali S, Frezza AM, Beretta A, Percio S, Lecchi M, Tortoreto M, Barisella M, Collini P, Dagrada GP, Merlini A, Huang PH, Jenks A, Jones RL, Tap WD, Ingrosso M, Morosi C, Brich S, Giani C, Verderio P, Casali PG, Leonard H, Gronchi A, Zuco V, Zaffaroni N. Stacchiotti S, et al. Among authors: beretta a. Clin Cancer Res. 2024 Nov 15;30(22):5122-5137. doi: 10.1158/1078-0432.CCR-23-3991. Clin Cancer Res. 2024. PMID: 39283723 Free PMC article.
188 results